Lipid nanoparticle drug system targets COVID-19 associated lung damage

A new drug delivery system developed by researchers at the University of Hawaiʻi at Mānoa John A. Burns School of Medicine (JABSOM) and Sungkyunkwan University in South Korea may significantly reduce serious lung damage. The study was published in the Journal of Controlled Release.